AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 139 filers reported holding AMICUS THERAPEUTICS INC in Q3 2016. The put-call ratio across all filers is 0.28 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $558,000 | -34.8% | 58,240 | -17.7% | 0.30% | -22.6% |
| Q3 2018 | $856,000 | +0.6% | 70,768 | +29.8% | 0.38% | +3.3% |
| Q2 2018 | $851,000 | -55.4% | 54,504 | -57.1% | 0.37% | -48.2% |
| Q1 2018 | $1,910,000 | -35.7% | 127,000 | -38.5% | 0.71% | -21.5% |
| Q4 2017 | $2,970,000 | +148.3% | 206,400 | +73.7% | 0.91% | +168.6% |
| Q2 2017 | $1,196,000 | -24.9% | 118,800 | -46.8% | 0.34% | -34.0% |
| Q1 2017 | $1,592,000 | +42.1% | 223,300 | -0.9% | 0.51% | +10.6% |
| Q4 2016 | $1,120,000 | +253.3% | 225,300 | +425.2% | 0.46% | +295.7% |
| Q3 2016 | $317,000 | – | 42,900 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 10,524,022 | $127,972,108 | 12.11% |
| Perceptive Advisors | 27,692,917 | $336,745,870 | 11.23% |
| Redmile Group, LLC | 16,944,621 | $206,046,591 | 9.80% |
| Finepoint Capital LP | 1,489,025 | $18,106,544 | 9.02% |
| CM Management, LLC | 450,000 | $5,472,000 | 5.81% |
| Avoro Capital Advisors LLC | 27,400,000 | $333,184,000 | 5.20% |
| MPM BioImpact LLC | 716,139 | $8,708,250 | 2.32% |
| Artal Group S.A. | 4,062,567 | $49,401 | 2.12% |
| SECTORAL ASSET MANAGEMENT INC | 803,464 | $9,770,122 | 1.90% |
| GREAT POINT PARTNERS LLC | 857,000 | $10,421,120 | 1.90% |